Market by Product Type, Gender, Application, End-user, and Regional Outlook | Forecast 2023-2030
Botulinum toxin is a
neurotoxic protein produced by Clostridium botulinum and related species. The
toxin is employed for medicinal and aesthetic purposes. In its cosmetic form,
it is also referred to as Botox, an injectable that temporarily minimizes or
gets rid of wrinkles and fine lines on the face. The most commonly treated
areas are forehead wrinkles, frown lines, and crow's feet. Other treated areas
include heavy jaw muscles, lip lines, gummy grins, and thick neck bands.
According to Triton Market Research’s report, the Global Botulinum Toxin Market was valued at $5796.12 million in 2022 and is expected to reach $12534.31 million by 2030, growing at a CAGR of 10.17% during the forecast period 2023-2030.
Click here to check out our blog on the Global Botulinum Toxin Market
MARKET
PERFORMANCE: DRIVERS, CHALLENGES, AND OPPORTUNITIES
Over the forecast period, a surge in demand for aesthetic procedures and
a rise in the geriatric population are expected to fuel the botulinum toxin
market’s expansion. According
to the UN, in 2017, there were an estimated 962 million people aged 60 or over
globally, comprising 13% of the global population. The number of older persons
worldwide is projected to be 1.4 billion by 2030 and 2.1 billion by 2050.
Hence, the increasing desire for people to achieve a youthful appearance, the
aging population, and the increased demand for non-surgical treatments have
elevated the demand for Botox to gain immediate results.
The market, however, might face challenges due to limited reimbursement
policies supporting cosmetic procedures, adverse effects of botulinum toxin,
and the emerging problem of botulinum type A resistance. In the healthcare sector, reimbursement,
coverage reform, payer and provider consolidation, and escalating healthcare
costs allow lesser adoption of newer advanced botulinum toxin products. The high cost of cosmetic procedures and poor
reimbursement policies across low-income countries are restraining factors for
the market's growth.
Nevertheless, the expansion of botulinum toxin into therapeutic
applications and rising medical tourism opens new avenues for the studied
market. There is a
significant trend of people traveling to less developed countries due to the
availability of high-quality treatment at low cost. Other than this, people opt
for medical tourism due to long waiting times, wait lists, or other reasons in
their home country. Additionally, cost is a major concern in the US, resulting
in people seeking cheaper options despite deductible costs not covered by
insurance.
Report scope can be customized per your requirements - Request Free Sample Report
KEY GEOGRAPHIES COVERED:
• North America: United States and Canada,
• Europe:
United Kingdom, France, Germany, Spain, Italy, Poland, and Rest of Europe
• Asia-Pacific:
China, Japan, India, Australia & New Zealand, South Korea, ASEAN Countries,
and Rest of Asia-Pacific
• Latin America: Brazil, Mexico, and Rest of Latin America
• Middle East and Africa: Saudi Arabia, Israel, United Arab Emirates, South Africa, and
Rest of Middle East & Africa
SEGMENTATION
ANALYSIS - BOTULINUM TOXIN MARKET:
• Market by Product Type:
o Type A
o Type B
Type
A is expected to witness the fastest growth in terms of product type. It blocks neuromuscular transmission by
binding to the acceptor sites of motor or sympathetic nerve terminals and
inhibiting acetylcholine release. Type A was first used for treating crossed
eyes. Later, it gained importance for cosmetic purposes, including wrinkles.
Some commonly known injections are Botox, Dysport, Xeomin, and Jeuveau. It also
treats various medical conditions, such as muscle spasms and migraines. For
instance, Bocouture, developed by Merz Pharmaceuticals, treats blepharospasm
and cervical dystonia.
• Market by Gender:
o Women
o Men
The
women category dominates the market based on gender. This is primarily caused by rising female skin
rejuvenation trends in middle age and increased aesthetic surgery rates. For
instance, according to the Aesthetic Society, more than 4.1 million females got
botulinum toxin surgery in 2020. Additionally, more than 2.5 million women
between the ages of 40 and 54 received botulinum toxin treatments in 2020,
demonstrating the market's potential for expansion.
• Market by Application:
o Aesthetic
• Crow’s
Feet
• Forehead
Lines
• Frown
Lines/Glabellar
• Square
Jaw/Masseter
• Other
Aesthetic Applications.
o Medical
• Chronic
Migraine
• Muscle
Spasm
• Overactive
Bladder
• Hyperhidrosis
• Other
Medical Applications
• Market by End-user:
o Specialty and Dermatology Clinics
o Hospitals and Clinics
o Other End-users
COMPETITIVE LANDSCAPE:
The botulinum toxin market by company profile
helps dive into data about the key players in this industry. The strategic
initiatives for each of the companies considered have been covered in detail.
Product
Development (April 2023): Galderma
Injectable poly-L-lactic acid
(PLLA-SCA) by Galderma received approval from the US Food and Drug
Administration (FDA) to treat wrinkles and fine lines around the cheeks.
When injected into the cheek area, it aids in promoting the creation of natural
collagen to reduce wrinkles and enhance skin characteristics, including
firmness and radiance.
Collaboration (February 2023): AbbVie Inc and Capsida Biotherapeutics
A strategic partnership
between Capsida Biotherapeutics Inc and AbbVie was established in February
2023 to create treatments for critical eye conditions. Capsida's
cutting-edge adeno-associated virus (AAV) engineering platform and
manufacturing competence will be combined with AbbVie's broad capabilities to
identify and advance programs.
Acquisition (October 2022): AbbVie Inc and DJS Antibodies Ltd
AbbVie acquired DJS
Antibodies Ltd, a privately held biotechnology firm focusing on developing
antibody therapeutics that target disease-causing proteins that are challenging
to treat, such as G protein-coupled receptors (GPCRs).
KEY BENEFITS OF THE REPORT:
● Triton Market Research has a collective experience of 25-30 years in the industry, with its analysts and experts encompassing the most infallible research methodology for its market intelligence and industry analysis.
● Our research methodology helps in achieving a broader consensus of the market size, shape, and industry trends within each industry segment.
● The strategy adopted in designing the research methodology includes the amalgamation of the information assembled from primary and secondary sources, with the assistance of analytical tools to construct the forecast and predictive models.
●
The scope of the market report comprises the current scenario of
the global botulinum toxin market, along with the detailed overview of the
industry outlook, market dynamics, segmentation analysis, regional outlook, and
competitive landscape for the period 2023-2030.
FAQs:
Q 1) What are the challenges for the botulinum toxin market?
One of the main challenges
for the botulinum toxin market is the upgrades and changes in reimbursement
policies and escalating healthcare costs, resulting in lesser adoption of newer
botulinum toxin products.
Q 2) Any promising trends that can prove a key investment pocket for the
botulinum toxin market?
The product approvals by
governments are likely to drive botox demand, thus offering a key investment
area for major players in the botulinum toxin market.
Market By Type, Application, E ..
VIEW REPORT
Market By Offerings, Technolog ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT1. GLOBAL
BOTULINUM TOXIN MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
ANALYSIS ON THE BOTULINUM TOXIN MARKET
2.1.1. COVID-19
IMPACT
2.2. KEY
INSIGHTS
2.2.1. GROWING
DEMAND FOR NON-INVASIVE COSMETIC PROCEDURES
2.2.2. SURGE
IN DEMAND FOR BOTULINUM TOXIN AMONG MILLENNIALS AND GEN-Z
2.3. PORTER’S
FIVE FORCES ANALYSIS
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTES
2.3.3. BARGAINING
POWER OF BUYERS
2.3.4. BARGAINING
POWER OF SUPPLIERS
2.3.5. THREAT
OF COMPETITIVE RIVALRY
2.4. MARKET
MATURITY ANALYSIS
2.5. REGULATORY
FRAMEWORK
2.6. KEY
MARKET STRATEGIES
2.6.1. PRODUCT
LAUNCHES
2.6.2. COLLABORATIONS
2.6.3. BUSINESS
EXPANSIONS & DIVESTITURES
2.6.4. ACQUISITIONS
2.7. MARKET
DRIVERS
2.7.1. SURGE
IN DEMAND FOR AESTHETIC PROCEDURES
2.7.2. RISE
IN GERIATRIC POPULATION
2.8. MARKET
CHALLENGES
2.8.1. LIMITED
REIMBURSEMENT POLICIES SUPPORTING COSMETIC PROCEDURES
2.8.2. ADVERSE
EFFECTS OF BOTULINUM TOXIN
2.8.3. EMERGING
PROBLEM OF BOTULINUM TOXIN TYPE A RESISTANCE
2.9. MARKET
OPPORTUNITIES
2.9.1. EXPANSION OF BOTULINUM TOXIN INTO THERAPEUTIC
APPLICATIONS
2.9.2. RISING
MEDICAL TOURISM
2.10. ANALYST
PERSPECTIVE
3. GLOBAL
BOTULINUM TOXIN MARKET OUTLOOK - BY PRODUCT TYPE
3.1. TYPE A
BOTULINUM TOXIN
3.2. TYPE B
BOTULINUM TOXIN
4. GLOBAL
BOTULINUM TOXIN MARKET OUTLOOK - BY GENDER
4.1. WOMEN
4.2. MEN
5. GLOBAL
BOTULINUM TOXIN MARKET OUTLOOK - BY APPLICATION
5.1. AESTHETIC
5.1.1. CROW’S
FEET
5.1.2. FOREHEAD
LINES
5.1.3. FROWN
LINES/GLABELLAR
5.1.4. SQUARE
JAW/MASSETER
5.1.5. OTHER
AESTHETIC APPLICATIONS
5.2. MEDICAL
5.2.1. CHRONIC
MIGRAINE
5.2.2. MUSCLE
SPASM
5.2.3. OVERACTIVE
BLADDER
5.2.4. HYPERHIDROSIS
5.2.5. OTHER
MEDICAL APPLICATIONS
6. GLOBAL
BOTULINUM TOXIN MARKET OUTLOOK - BY END-USER
6.1. SPECIALTY
AND DERMATOLOGY CLINICS
6.2. HOSPITALS
AND CLINICS
6.3. OTHER
END-USERS
7. GLOBAL
BOTULINUM TOXIN MARKET – BY REGIONAL OUTLOOK
7.1. NORTH
AMERICA
7.1.1. MARKET
BY PRODUCT TYPE
7.1.2. MARKET
BY GENDER
7.1.3. MARKET
BY APPLICATION
7.1.3.1. MARKET
BY AESTHETIC
7.1.3.2. MARKET
BY MEDICAL
7.1.4. MARKET
BY END-USER
7.1.5. COUNTRY
ANALYSIS
7.1.5.1. UNITED
STATES
7.1.5.1.1. UNITED
STATES BOTULINUM TOXIN MARKET FORECAST & PROSPECTS
7.1.5.2. CANADA
7.1.5.2.1. CANADA
BOTULINUM TOXIN MARKET FORECAST & PROSPECTS
7.2. EUROPE
7.2.1. MARKET
BY PRODUCT TYPE
7.2.2. MARKET
BY GENDER
7.2.3. MARKET
BY APPLICATION
7.2.3.1. MARKET
BY AESTHETIC
7.2.3.2. MARKET
BY MEDICAL
7.2.4. MARKET
BY END-USER
7.2.5. COUNTRY
ANALYSIS
7.2.5.1. UNITED
KINGDOM
7.2.5.1.1. UNITED
KINGDOM BOTULINUM TOXIN MARKET FORECAST & PROSPECTS
7.2.5.2. GERMANY
7.2.5.2.1. GERMANY
BOTULINUM TOXIN MARKET FORECAST & PROSPECTS
7.2.5.3. FRANCE
7.2.5.3.1. FRANCE
BOTULINUM TOXIN MARKET FORECAST & PROSPECTS
7.2.5.4. ITALY
7.2.5.4.1. ITALY
BOTULINUM TOXIN MARKET FORECAST & PROSPECTS
7.2.5.5. SPAIN
7.2.5.5.1. SPAIN
BOTULINUM TOXIN MARKET FORECAST & PROSPECTS
7.2.5.6. POLAND
7.2.5.6.1. POLAND
BOTULINUM TOXIN MARKET FORECAST & PROSPECTS
7.2.5.7. REST
OF EUROPE
7.2.5.7.1. REST
OF EUROPE BOTULINUM TOXIN MARKET FORECAST & PROSPECTS
7.3. ASIA-PACIFIC
7.3.1. MARKET
BY PRODUCT TYPE
7.3.2. MARKET
BY GENDER
7.3.3. MARKET
BY APPLICATION
7.3.3.1. MARKET
BY AESTHETIC
7.3.3.2. MARKET
BY MEDICAL
7.3.4. MARKET
BY END-USER
7.3.5. COUNTRY
ANALYSIS
7.3.5.1. CHINA
7.3.5.1.1. CHINA
BOTULINUM TOXIN MARKET FORECAST & PROSPECTS
7.3.5.2. JAPAN
7.3.5.2.1. JAPAN
BOTULINUM TOXIN MARKET FORECAST & PROSPECTS
7.3.5.3. INDIA
7.3.5.3.1. INDIA
BOTULINUM TOXIN MARKET FORECAST & PROSPECTS
7.3.5.4. SOUTH
KOREA
7.3.5.4.1. SOUTH
KOREA BOTULINUM TOXIN MARKET FORECAST & PROSPECTS
7.3.5.5. ASEAN
COUNTRIES
7.3.5.5.1. ASEAN
COUNTRIES BOTULINUM TOXIN MARKET FORECAST & PROSPECTS
7.3.5.6. AUSTRALIA
& NEW ZEALAND
7.3.5.6.1. AUSTRALIA
& NEW ZEALAND BOTULINUM TOXIN MARKET FORECAST & PROSPECTS
7.3.5.7. REST
OF ASIA-PACIFIC
7.3.5.7.1. REST
OF ASIA-PACIFIC BOTULINUM TOXIN MARKET FORECAST & PROSPECTS
7.4. LATIN
AMERICA
7.4.1. MARKET
BY TYPE
7.4.2. MARKET
BY GENDER
7.4.3. MARKET
BY APPLICATION
7.4.3.1. MARKET
BY AESTHETIC
7.4.3.2. MARKET
BY MEDICAL
7.4.4. MARKET
BY END-USER
7.4.5. COUNTRY
ANALYSIS
7.4.5.1. BRAZIL
7.4.5.1.1. BRAZIL
BOTULINUM TOXIN MARKET FORECAST & PROSPECTS
7.4.5.2. MEXICO
7.4.5.2.1. MEXICO
BOTULINUM TOXIN MARKET FORECAST & PROSPECTS
7.4.5.3. REST
OF LATIN AMERICA
7.4.5.3.1. REST
OF LATIN AMERICA BOTULINUM TOXIN MARKET FORECAST & PROSPECTS
7.5. MIDDLE
EAST AND AFRICA
7.5.1. MARKET
BY PRODUCT TYPE
7.5.2. MARKET
BY GENDER
7.5.3. MARKET
BY APPLICATION
7.5.3.1. MARKET
BY AESTHETIC
7.5.3.2. MARKET
BY MEDICAL
7.5.4. MARKET
BY END-USER
7.5.5. COUNTRY
ANALYSIS
7.5.5.1. UNITED
ARAB EMIRATES
7.5.5.1.1. UNITED
ARAB EMIRATES BOTULINUM TOXIN MARKET FORECAST & PROSPECTS
7.5.5.2. SAUDI
ARABIA
7.5.5.2.1. SAUDI
ARABIA BOTULINUM TOXIN MARKET FORECAST & PROSPECTS
7.5.5.3. ISRAEL
7.5.5.3.1. ISRAEL
BOTULINUM TOXIN MARKET FORECAST & PROSPECTS
7.5.5.4. SOUTH
AFRICA
7.5.5.4.1. SOUTH
AFRICA BOTULINUM TOXIN MARKET FORECAST & PROSPECTS
7.5.5.5. REST
OF MIDDLE EAST & AFRICA
7.5.5.5.1. REST
OF MIDDLE EAST & AFRICA BOTULINUM TOXIN MARKET FORECAST & PROSPECTS
8. COMPETITIVE
LANDSCAPE
8.1. ABBVIE
INC
8.1.1. OVERVIEW
8.1.2. PRODUCT
PORTFOLIO
8.1.3. KEY
STRENGTHS
8.1.4. KEY
CHALLENGES
8.2. EVOLUS
INC
8.2.1. OVERVIEW
8.2.2. PRODUCT
PORTFOLIO
8.2.3. KEY
STRENGTHS
8.2.4. KEY
CHALLENGES
8.3. MEDYTOX
INC
8.3.1. OVERVIEW
8.3.2. PRODUCT
PORTFOLIO
8.3.3. KEY
STRENGTHS
8.3.4. KEY
CHALLENGES
8.4. LANZHOU
INSTITUTE OF BIOLOGICAL PRODUCTS CO LTD
8.4.1. OVERVIEW
8.4.2. PRODUCT
PORTFOLIO
8.4.3. KEY
STRENGTHS
8.4.4. KEY
CHALLENGES
8.5. DAEWOONG
PHARMACEUTICAL CO LTD
8.5.1. OVERVIEW
8.5.2. PRODUCT
PORTFOLIO
8.5.3. KEY
STRENGTHS
8.5.4. KEY
CHALLENGES
8.6. GALDERMA
SA
8.6.1. OVERVIEW
8.6.2. PRODUCT
PORTFOLIO
8.6.3. KEY
STRENGTHS
8.6.4. KEY
CHALLENGES
8.7. IPSEN
PHARMA
8.7.1. OVERVIEW
8.7.2. PRODUCT
PORTFOLIO
8.7.3. KEY
STRENGTHS
8.7.4. KEY
CHALLENGES
8.8. HUGEL
INC
8.8.1. OVERVIEW
8.8.2. PRODUCT
PORTFOLIO
8.8.3. KEY
STRENGTHS
8.8.4. KEY
CHALLENGES
8.9. CANDELA
MEDICAL CORPORATION
8.9.1. OVERVIEW
8.9.2. PRODUCT
PORTFOLIO
8.9.3. KEY
STRENGTHS
8.9.4. KEY
CHALLENGES
8.10. MERZ
PHARMA GMBH & CO KGAA
8.10.1. OVERVIEW
8.10.2. PRODUCT
PORTFOLIO
8.10.3. KEY
STRENGTHS
8.10.4. KEY
CHALLENGES
8.11. REVANCE
THERAPEUTICS INC
8.11.1. OVERVIEW
8.11.2. PRODUCT
PORTFOLIO
8.12. US
WORLDMEDS LLC
8.12.1. OVERVIEW
8.12.2. PRODUCT
PORTFOLIO
9. RESEARCH
METHODOLOGY & SCOPE
9.1. RESEARCH
SCOPE & DELIVERABLES
9.2. SOURCES
OF DATA
9.3. RESEARCH
METHODOLOGY
TABLE
1: GLOBAL BOTULINUM TOXIN MARKET, BY REGIONAL OUTLOOK, 2023-2030 (IN $ MILLION)
TABLE
2: COUNTRY-WISE REGULATORY FRAMEWORK FOR BOTULINUM TOXIN
TABLE
3: LIST OF PRODUCT LAUNCHES
TABLE
4: LIST OF COLLABORATIONS
TABLE
5: LIST OF BUSINESS EXPANSIONS & DIVESTITURES
TABLE
6: LIST OF ACQUISITIONS
TABLE
7: EXAMPLE OF COMMERCIALLY AVAILABLE BOTULINUM TOXIN TYPE A FOR AESTHETIC
PROCEDURES
TABLE
8: GLOBAL BOTULINUM TOXIN MARKET, BY PRODUCT TYPE, 2023-2030 (IN $ MILLION)
TABLE
9: GLOBAL BOTULINUM TOXIN MARKET, BY GENDER, 2023-2030 (IN $ MILLION)
TABLE
10: GLOBAL BOTULINUM TOXIN MARKET, BY APPLICATION, 2023-2030 (IN $ MILLION)
TABLE
11: GLOBAL BOTULINUM TOXIN MARKET, BY AESTHETIC, 2023-2030 (IN $ MILLION)
TABLE
12: GLOBAL BOTULINUM TOXIN MARKET, BY MEDICAL, 2023-2030 (IN $ MILLION)
TABLE
13: GLOBAL BOTULINUM TOXIN MARKET, BY END-USER, 2023-2030 (IN $ MILLION)
TABLE
14: GLOBAL BOTULINUM TOXIN MARKET, BY REGIONAL OUTLOOK, 2023-2030 (IN $
MILLION)
TABLE
15: NORTH AMERICA BOTULINUM TOXIN MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $
MILLION)
TABLE
16: NORTH AMERICA BOTULINUM TOXIN MARKET, BY PRODUCT TYPE, 2023-2030 (IN $
MILLION)
TABLE
17: NORTH AMERICA BOTULINUM TOXIN MARKET, BY GENDER, 2023-2030 (IN $ MILLION)
TABLE
18: NORTH AMERICA BOTULINUM TOXIN MARKET, BY APPLICATION, 2023-2030 (IN $
MILLION)
TABLE
19: NORTH AMERICA BOTULINUM TOXIN MARKET, BY AESTHETIC, 2023-2030 (IN $
MILLION)
TABLE
20: NORTH AMERICA BOTULINUM TOXIN MARKET, BY MEDICAL, 2023-2030 (IN $ MILLION)
TABLE
21: NORTH AMERICA BOTULINUM TOXIN MARKET, BY END-USER, 2023-2030 (IN $ MILLION)
TABLE
22: EUROPE BOTULINUM TOXIN MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)
TABLE
23: EUROPE BOTULINUM TOXIN MARKET, BY PRODUCT TYPE, 2023-2030 (IN $ MILLION)
TABLE
24: EUROPE BOTULINUM TOXIN MARKET, BY GENDER, 2023-2030 (IN $ MILLION)
TABLE
25: EUROPE BOTULINUM TOXIN MARKET, BY APPLICATION, 2023-2030 (IN $ MILLION)
TABLE
26: EUROPE BOTULINUM TOXIN MARKET, BY AESTHETIC, 2023-2030 (IN $ MILLION)
TABLE
27: EUROPE BOTULINUM TOXIN MARKET, BY MEDICAL, 2023-2030 (IN $ MILLION)
TABLE
28: EUROPE BOTULINUM TOXIN MARKET, BY END-USER, 2023-2030 (IN $ MILLION)
TABLE
29: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $
MILLION)
TABLE
30: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY PRODUCT TYPE, 2023-2030 (IN $
MILLION)
TABLE
31: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY GENDER, 2023-2030 (IN $ MILLION)
TABLE
32: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY APPLICATION, 2023-2030 (IN $
MILLION)
TABLE
33: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY AESTHETIC, 2023-2030 (IN $ MILLION)
TABLE
34: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY MEDICAL, 2023-2030 (IN $ MILLION)
TABLE
35: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY END-USER, 2023-2030 (IN $ MILLION)
TABLE
36: LATIN AMERICA BOTULINUM TOXIN MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $
MILLION)
TABLE
37: LATIN AMERICA BOTULINUM TOXIN MARKET, BY TYPE, 2023-2030 (IN $ MILLION)
TABLE
38: LATIN AMERICA BOTULINUM TOXIN MARKET, BY GENDER, 2023-2030 (IN $ MILLION)
TABLE
39: LATIN AMERICA BOTULINUM TOXIN MARKET, BY APPLICATION, 2023-2030 (IN $
MILLION)
TABLE
40: LATIN AMERICA BOTULINUM TOXIN MARKET, BY AESTHETIC, 2023-2030 (IN $
MILLION)
TABLE
41: LATIN AMERICA BOTULINUM TOXIN MARKET, BY MEDICAL, 2023-2030 (IN $ MILLION)
TABLE
42: LATIN AMERICA BOTULINUM TOXIN MARKET, BY END-USER, 2023-2030 (IN $ MILLION)
TABLE
43: MIDDLE EAST AND AFRICA BOTULINUM TOXIN MARKET, BY COUNTRY OUTLOOK,
2023-2030 (IN $ MILLION)
TABLE
44: MIDDLE EAST AND AFRICA BOTULINUM TOXIN MARKET, BY PRODUCT TYPE, 2023-2030
(IN $ MILLION)
TABLE
45: MIDDLE EAST AND AFRICA BOTULINUM TOXIN MARKET, BY GENDER, 2023-2030 (IN $
MILLION)
TABLE
46: MIDDLE EAST AND AFRICA BOTULINUM TOXIN MARKET, BY APPLICATION, 2023-2030
(IN $ MILLION)
TABLE
47: MIDDLE EAST AND AFRICA BOTULINUM TOXIN MARKET, BY AESTHETIC, 2023-2030 (IN
$ MILLION)
TABLE
48: MIDDLE EAST AND AFRICA BOTULINUM TOXIN MARKET, BY MEDICAL, 2023-2030 (IN $
MILLION)
TABLE
49: MIDDLE EAST AND AFRICA BOTULINUM TOXIN MARKET, BY END-USER, 2023-2030 (IN $
MILLION)
FIGURE 1: MARKET MATURITY ANALYSIS
FIGURE 2: GLOBAL BOTULINUM TOXIN MARKET, BY PRODUCT
TYPE, 2022 & 2030 (IN %)
FIGURE 3: GLOBAL BOTULINUM TOXIN MARKET, BY TYPE A
BOTULINUM TOXIN, 2023-2030 (IN $ MILLION)
FIGURE 4: GLOBAL BOTULINUM TOXIN MARKET, BY TYPE B
BOTULINUM TOXIN, 2023-2030 (IN $ MILLION)
FIGURE 5: GLOBAL BOTULINUM TOXIN MARKET, BY GENDER,
2022 & 2030 (IN %)
FIGURE 6: GLOBAL BOTULINUM TOXIN MARKET, BY WOMEN,
2023-2030 (IN $ MILLION)
FIGURE 7: GLOBAL BOTULINUM TOXIN MARKET, BY MEN,
2023-2030 (IN $ MILLION)
FIGURE 8: GLOBAL BOTULINUM TOXIN MARKET, BY
APPLICATION, 2022 & 2030 (IN %)
FIGURE 9: GLOBAL BOTULINUM TOXIN MARKET, BY
AESTHETIC, 2023-2030 (IN $ MILLION)
FIGURE 10: GLOBAL BOTULINUM TOXIN MARKET, BY AESTHETIC,
2022 & 2030 (IN %)
FIGURE 11: GLOBAL BOTULINUM TOXIN MARKET, BY CROW’S
FEET, 2023-2030 (IN $ MILLION)
FIGURE 12: GLOBAL BOTULINUM TOXIN MARKET, BY
FOREHEAD LINES, 2023-2030 (IN $ MILLION)
FIGURE 13: GLOBAL BOTULINUM TOXIN MARKET, BY FROWN
LINES/GLABELLAR, 2023-2030 (IN $ MILLION)
FIGURE 14: GLOBAL BOTULINUM TOXIN MARKET, BY SQUARE JAW/MASSETER,
2023-2030 (IN $ MILLION)
FIGURE 15: GLOBAL BOTULINUM TOXIN MARKET, BY OTHER
AESTHETIC APPLICATIONS, 2023-2030 (IN $ MILLION)
FIGURE 16: GLOBAL BOTULINUM TOXIN MARKET, BY
MEDICAL, 2023-2030 (IN $ MILLION)
FIGURE 17: GLOBAL BOTULINUM TOXIN MARKET, BY
MEDICAL, 2022 & 2030 (IN %)
FIGURE 18: GLOBAL BOTULINUM TOXIN MARKET, BY CHRONIC
MIGRAINE, 2023-2030 (IN $ MILLION)
FIGURE 19: GLOBAL BOTULINUM TOXIN MARKET, BY MUSCLE
SPASM, 2023-2030 (IN $ MILLION)
FIGURE 20: GLOBAL BOTULINUM TOXIN MARKET, BY OVERACTIVE
BLADDER, 2023-2030 (IN $ MILLION)
FIGURE 21: GLOBAL BOTULINUM TOXIN MARKET, BY
HYPERHIDROSIS, 2023-2030 (IN $ MILLION)
FIGURE 22: GLOBAL BOTULINUM TOXIN MARKET, BY OTHER
MEDICAL APPLICATIONS, 2023-2030 (IN $ MILLION)
FIGURE 23: GLOBAL BOTULINUM TOXIN MARKET, BY
END-USER, 2022 & 2030 (IN %)
FIGURE 24: GLOBAL BOTULINUM TOXIN MARKET, BY
SPECIALTY AND DERMATOLOGY CLINICS, 2023-2030 (IN $ MILLION)
FIGURE 25: GLOBAL BOTULINUM TOXIN MARKET, BY
HOSPITALS AND CLINICS, 2023-2030 (IN $ MILLION)
FIGURE 26: GLOBAL BOTULINUM TOXIN MARKET, BY OTHER
END-USERS, 2023-2030 (IN $ MILLION)
FIGURE 27: GLOBAL BOTULINUM TOXIN MARKET, BY
REGIONAL OUTLOOK, 2022 & 2030 (IN %)
FIGURE 28: UNITED STATES BOTULINUM TOXIN MARKET
2023-2030 (IN $ MILLION)
FIGURE 29: CANADA BOTULINUM TOXIN MARKET 2023-2030
(IN $ MILLION)
FIGURE 30: UNITED KINGDOM BOTULINUM TOXIN MARKET
2023-2030 (IN $ MILLION)
FIGURE 31: GERMANY BOTULINUM TOXIN MARKET 2023-2030
(IN $ MILLION)
FIGURE 32: FRANCE BOTULINUM TOXIN MARKET 2023-2030
(IN $ MILLION)
FIGURE 33: ITALY BOTULINUM TOXIN MARKET 2023-2030
(IN $ MILLION)
FIGURE 34: SPAIN BOTULINUM TOXIN MARKET 2023-2030
(IN $ MILLION)
FIGURE 35: POLAND BOTULINUM TOXIN MARKET 2023-2030
(IN $ MILLION)
FIGURE 36: REST OF EUROPE BOTULINUM TOXIN MARKET
2023-2030 (IN $ MILLION)
FIGURE 37: CHINA BOTULINUM TOXIN MARKET 2023-2030
(IN $ MILLION)
FIGURE 38: JAPAN BOTULINUM TOXIN MARKET 2023-2030
(IN $ MILLION)
FIGURE 39: INDIA BOTULINUM TOXIN MARKET 2023-2030
(IN $ MILLION)
FIGURE 40: SOUTH KOREA BOTULINUM TOXIN MARKET
2023-2030 (IN $ MILLION)
FIGURE 41: ASEAN COUNTRIES BOTULINUM TOXIN MARKET
2023-2030 (IN $ MILLION)
FIGURE 42: AUSTRALIA & NEW ZEALAND BOTULINUM
TOXIN MARKET 2023-2030 (IN $ MILLION)
FIGURE 43: REST OF ASIA-PACIFIC BOTULINUM TOXIN
MARKET 2023-2030 (IN $ MILLION)
FIGURE 44: BRAZIL BOTULINUM TOXIN MARKET 2023-2030
(IN $ MILLION)
FIGURE 45: MEXICO BOTULINUM TOXIN MARKET 2023-2030
(IN $ MILLION)
FIGURE 46: REST OF LATIN AMERICA BOTULINUM TOXIN
MARKET 2023-2030 (IN $ MILLION)
FIGURE 47: UNITED ARAB EMIRATES BOTULINUM TOXIN MARKET
2023-2030 (IN $ MILLION)
FIGURE 48: SAUDI ARABIA BOTULINUM TOXIN MARKET
2023-2030 (IN $ MILLION)
FIGURE 49: ISRAEL BOTULINUM TOXIN MARKET 2023-2030
(IN $ MILLION)
FIGURE 50: SOUTH AFRICA BOTULINUM TOXIN MARKET
2023-2030 (IN $ MILLION)
FIGURE 51: REST OF MIDDLE EAST & AFRICA
BOTULINUM TOXIN MARKET 2023-2030 (IN $ MILLION)